Compound 2227
Identifiers
- Canonical SMILES:
O=c1[nH]c(=O)c2c(ccnc2n1CC1CCCO1)-c1ccco1
- IUPAC name:
5-(furan-2-yl)-1-[(oxolan-2-yl)methyl]-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-2,4-dione
- InChi:
InChI=1S/C16H15N3O4/c20-15-13-11(12-4-2-8-23-12)5-6-17-14(13)19(16(21)18-15)9-10-3-1-7-22-10/h2,4-6,8,10H,1,3,7,9H2,(H,18,20,21)
- InChiKey:
OIEHAXQSKYVIJF-UHFFFAOYSA-N
External links
![]() 16414715 |
![]() CHEMBL4080143 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 3.89 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 313.11 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 1.11 | |||
TPSA | 84.67 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4802 | Etofylline nicotinate | DB13842 | |
0.4793 | Verdiperstat | DB12440 | |
0.4783 | LY-3023414 | DB12167 | |
0.4503 | Uridine | DB02745 | |
0.4444 | Inosine | DB04335 | |
0.4417 | Proquazone | DB13649 | |
0.4402 | 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID | DB07827 | |
0.4392 | 3'-deoxyguanosine | DB03609 | |
0.4364 | Doxofylline | DB09273 | |
0.4355 | Uridine triacetate | DB09144 | |
0.4335 | Didanosine | DB00900 | |
0.4323 | Guanosine | DB02857 | |
0.4314 | 5-monophosphate-9-beta-D-ribofuranosyl xanthine | DB02309 | |
0.4309 | Doxifluridine | DB12947 | |
0.4308 | 7-Methylguanosine | DB03493 |